Health
Results: 1357-1368 of 10153

YuLife turns June into a movement for good, bringing Bupa's Healthy Cities programme to its full UK member base

Alcohol industry demonstrates near universal compliance with the Portman Group’s health labelling guidelines

AbbVie Announces European Commission Approval of AQUIPTA® (atogepant) for the Acute Treatment of Migraine in Adults

Greywolf Therapeutics reports durable clinical responses with first-in-class oral ERAP1 inhibitor GRWD5769 across six solid tumor types



